Seeking Alpha

Don't panic over biotech selloff, Bernstein Research says

  • Biotech stocks suffer a third straight day of heavy losses after recording their worst selloff in two years yesterday, but Bernstein’s Geoffrey Porges says it's not time to panic.
  • Stocks with major uncertain events looming, such as MDVN, or with significant revenue upside already built into valuation, such as PCYC, were among the most severely affected, Porges says, but "nothing changed in the environment to suggest that those events were any more or less likely to have positive outcomes yesterday, or to suggest that revenue potential was any more or less likely to be achieved than was previously expected."
  • Still, investors shouldn’t buy the sector willy-nilly; Porges recommends Celgene (CELG) and Gilead (GILD) among large caps, and notes that less-pricey stocks such as Amgen (AMGN) should hold up better, as should midcaps with earnings and products, such as Alexion (ALXN).
From other sites
Comments (3)
  • wapiti
    , contributor
    Comments (711) | Send Message
    I'm not! CRAMMER will cram them down your throats again tonight! Like he does every night..along with BWLD, LNKD, FB, TSCO, YELP,etc.. Get the picture??
    9 Oct 2013, 12:54 PM Reply Like
  • Drew Robertson
    , contributor
    Comments (350) | Send Message
    You're right it's not just biotechs it's all MOMOs. Here's a good list.
    9 Oct 2013, 01:15 PM Reply Like
  • chicagomary
    , contributor
    Comments (189) | Send Message
    these biotech pullbacks are good buying of IBB biotech etf
    10 Oct 2013, 01:19 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs